Today, Kindra, the sex-positive vaginal health brand, announced the launch of the first-ever comprehensive vaginal health product system – the Daily V System. The 4-part daily regimen of Kindra products includes: Daily Vaginal Lotion, V Relief Serum, Soothe Bath Soak and the Core Supplement meant to support vulvar and vaginal skin for optimal vaginal health and sexual wellness. This hormone-free system is designed to provide targeted relief and support for…
Ovia Health by Labcorp (Ovia) today announced it will offer a first-of-its-kind Fertility and Family Building Benefit, providing companies and health plans a comprehensive and customizable solution to support the diverse family-building journeys of their employees and health plan members. “Compared to existing fertility point solutions that approach fertility health as a single point in time, we designed our Fertility and Family Building…
Pioneer Group has announced an investment in Béa Fertility to further expand the company’s at-home fertility treatment programme. Proceeds will be used to fuel growth in the UK market and achieve FDA clearance ahead of US commercialisation. The Béa Treatment Programme starts with a 5-minute Online Medical Consultation. Once suitability is assessed, the Béa Treatment Programme commences with an at-home Intracervical Insemination…
Texas A&M University Health Science Center (Texas A&M Health) and Philips (NYSE: PHG, AEX: PHIA), a global leader in health technology, are collaborating to improve health outcomes for mothers, children and families. The collaboration centers on the Pregnancy+ App, which supports parents from the moment they discover they are pregnant through childbirth by offering personalized content, expert- written information, as well as interactive 3D models…
Gynesonics, a women’s healthcare company focused on the development of minimally invasive solutions for symptomatic uterine fibroids, is pleased to announce that it has secured an incremental $42.5 million in financing (total of $67.2M inclusive of initial April 2023 financing). The round was led by existing Gynesonics investors Amzak Health, Endeavour Vision, Kaiser Permanente Ventures, Runway Growth Capital, and Bain Capital; with new…
Signos, a comprehensive metabolic health platform that includes a proprietary AI-engine with a continuous glucose monitor (CGM) to provide real-time data and recommendations for healthy weight management, announced $20 million in Series B funding to respond to the obesity and metabolic health crisis plaguing the US. This new round will allow Signos to expand its core team and platform and conduct additional…
